Optiver Holding’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13K Hold
1,603
﹤0.01% 2039
2025
Q4
$2.48K Hold
1,603
﹤0.01% 1888
2025
Q3
$2.53K Hold
1,603
﹤0.01% 2281
2025
Q2
$3.5K Buy
1,603
+712
+80% +$1.72K ﹤0.01% 1271
2025
Q1
$2.43K Buy
891
+458
+106% +$1.81K ﹤0.01% 1215
2024
Q4
$1.8K Buy
433
+110
+34% +$416 ﹤0.01% 954
2024
Q3
$1.26K Sell
323
-464
-59% -$1.96K ﹤0.01% 891
2024
Q2
$3.08K Buy
787
+211
+37% +$908 ﹤0.01% 825
2024
Q1
$2.41K Buy
+576
New +$2.7K ﹤0.01% 656

Other funds holding MXCT

Optiver Holding's MXCT Position: Q1 2026 in Review

Optiver Holding held its MaxCyte (MXCT) position steady in Q1 2026 at 1,603 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

Optiver Holding first reported a position in MXCT in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.5K in Q2 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Optiver Holding held 1,603 shares of MaxCyte worth $1.13K as of Q1 2026.
  • Optiver Holding left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2039 holding.
  • Optiver Holding first reported a position in MaxCyte in Q1 2024 and has held it in 9 quarters since.
  • Optiver Holding's MaxCyte position peaked at $3.5K in Q2 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.